APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026

26 December 2025216 pages

Choose your research edition.

Industry ResearchInfluenza Drugs and Vaccines Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Influenza Drugs and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Influenza Drugs and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Influenza Drugs and Vaccines market include CSL, Alvogen, AstraZeneca, BioCryst Pharmaceuticals, Bristol Myers Squibb, Celgene, Emergent Biosolutions, GlaxoSmithKline and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Influenza Drugs and Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza Drugs and Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza Drugs and Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Influenza Drugs and Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza Drugs and Vaccines Segment by Company

CSL

Alvogen

AstraZeneca

BioCryst Pharmaceuticals

Bristol Myers Squibb

Celgene

Emergent Biosolutions

GlaxoSmithKline

Hulan Bio

Protein Sciences Corporation

Seqirus

Serum Institute of India

Viatris

Beike Bio

Bayer

Pfizer

Jiangsu GDK

Sinovac

Eli Lilly

Roche

Novartis

Sanofi

Changchun Institute of Biological

Influenza Drugs and Vaccines Segment by Type

Influenza Drugs

Influenza Vaccines

Influenza Drugs and Vaccines Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Influenza Drugs and Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Influenza Drugs and Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Influenza Drugs and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Influenza Drugs and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Influenza Drugs and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Influenza Drugs and Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Influenza Drugs and Vaccines industry.

Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Influenza Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Influenza Drugs and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Influenza Drugs and Vaccines Industry Trends Table 2. Influenza Drugs and Vaccines Industry Drivers Table 3. Influenza Drugs and Vaccines Industry Opportunities and Challenges Table 4. Influenza Drugs and Vaccines Industry Restraints Table 5. Global Influenza Drugs and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Influenza Drugs and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Influenza Drugs and Vaccines Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Influenza Drugs and Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Influenza Drugs and Vaccines Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Influenza Drugs and Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Influenza Drugs and Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Influenza Drugs and Vaccines Company, Product Type & Application Table 13. Global Influenza Drugs and Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Influenza Drugs Table 18. Significant Companies of Influenza Vaccines Table 19. Global Influenza Drugs and Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Influenza Drugs and Vaccines Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Influenza Drugs and Vaccines Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Influenza Drugs and Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Influenza Drugs and Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Influenza Drugs and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Influenza Drugs and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Influenza Drugs and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Influenza Drugs and Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Influenza Drugs and Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Hospital Pharmacy Table 32. Global Influenza Drugs and Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Influenza Drugs and Vaccines Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Influenza Drugs and Vaccines Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Influenza Drugs and Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global Influenza Drugs and Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global Influenza Drugs and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Influenza Drugs and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Influenza Drugs and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Influenza Drugs and Vaccines Sales Value Share by Application (2021-2026) Table 41. Global Influenza Drugs and Vaccines Sales Value Share by Application (2027-2032) Table 42. Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (Tons) Table 44. Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Influenza Drugs and Vaccines Sales by Region (2027-2032) & (Tons) Table 46. Global Influenza Drugs and Vaccines Sales Market Share by Region (2027-2032) Table 47. Global Influenza Drugs and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Influenza Drugs and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Influenza Drugs and Vaccines Sales Value Share by Region (2021-2026) Table 50. Global Influenza Drugs and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Influenza Drugs and Vaccines Sales Value Share by Region (2027-2032) Table 52. Global Influenza Drugs and Vaccines Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global Influenza Drugs and Vaccines Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Influenza Drugs and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 57. Global Influenza Drugs and Vaccines Sales Market Share by Country (2021-2026) Table 58. Global Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 59. Global Influenza Drugs and Vaccines Sales Market Share by Country (2027-2032) Table 60. Global Influenza Drugs and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Influenza Drugs and Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global Influenza Drugs and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Influenza Drugs and Vaccines Sales Value Market Share by Country (2027-2032) Table 64. CSL Company Information Table 65. CSL Business Overview Table 66. CSL Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. CSL Influenza Drugs and Vaccines Product Portfolio Table 68. CSL Recent Development Table 69. Alvogen Company Information Table 70. Alvogen Business Overview Table 71. Alvogen Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. Alvogen Influenza Drugs and Vaccines Product Portfolio Table 73. Alvogen Recent Development Table 74. AstraZeneca Company Information Table 75. AstraZeneca Business Overview Table 76. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. AstraZeneca Influenza Drugs and Vaccines Product Portfolio Table 78. AstraZeneca Recent Development Table 79. BioCryst Pharmaceuticals Company Information Table 80. BioCryst Pharmaceuticals Business Overview Table 81. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio Table 83. BioCryst Pharmaceuticals Recent Development Table 84. Bristol Myers Squibb Company Information Table 85. Bristol Myers Squibb Business Overview Table 86. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio Table 88. Bristol Myers Squibb Recent Development Table 89. Celgene Company Information Table 90. Celgene Business Overview Table 91. Celgene Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. Celgene Influenza Drugs and Vaccines Product Portfolio Table 93. Celgene Recent Development Table 94. Emergent Biosolutions Company Information Table 95. Emergent Biosolutions Business Overview Table 96. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 97. Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio Table 98. Emergent Biosolutions Recent Development Table 99. GlaxoSmithKline Company Information Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 102. GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio Table 103. GlaxoSmithKline Recent Development Table 104. Hulan Bio Company Information Table 105. Hulan Bio Business Overview Table 106. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 107. Hulan Bio Influenza Drugs and Vaccines Product Portfolio Table 108. Hulan Bio Recent Development Table 109. Protein Sciences Corporation Company Information Table 110. Protein Sciences Corporation Business Overview Table 111. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 112. Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio Table 113. Protein Sciences Corporation Recent Development Table 114. Seqirus Company Information Table 115. Seqirus Business Overview Table 116. Seqirus Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 117. Seqirus Influenza Drugs and Vaccines Product Portfolio Table 118. Seqirus Recent Development Table 119. Serum Institute of India Company Information Table 120. Serum Institute of India Business Overview Table 121. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 122. Serum Institute of India Influenza Drugs and Vaccines Product Portfolio Table 123. Serum Institute of India Recent Development Table 124. Viatris Company Information Table 125. Viatris Business Overview Table 126. Viatris Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 127. Viatris Influenza Drugs and Vaccines Product Portfolio Table 128. Viatris Recent Development Table 129. Beike Bio Company Information Table 130. Beike Bio Business Overview Table 131. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 132. Beike Bio Influenza Drugs and Vaccines Product Portfolio Table 133. Beike Bio Recent Development Table 134. Bayer Company Information Table 135. Bayer Business Overview Table 136. Bayer Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 137. Bayer Influenza Drugs and Vaccines Product Portfolio Table 138. Bayer Recent Development Table 139. Pfizer Company Information Table 140. Pfizer Business Overview Table 141. Pfizer Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 142. Pfizer Influenza Drugs and Vaccines Product Portfolio Table 143. Pfizer Recent Development Table 144. Jiangsu GDK Company Information Table 145. Jiangsu GDK Business Overview Table 146. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 147. Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio Table 148. Jiangsu GDK Recent Development Table 149. Sinovac Company Information Table 150. Sinovac Business Overview Table 151. Sinovac Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 152. Sinovac Influenza Drugs and Vaccines Product Portfolio Table 153. Sinovac Recent Development Table 154. Eli Lilly Company Information Table 155. Eli Lilly Business Overview Table 156. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 157. Eli Lilly Influenza Drugs and Vaccines Product Portfolio Table 158. Eli Lilly Recent Development Table 159. Roche Company Information Table 160. Roche Business Overview Table 161. Roche Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 162. Roche Influenza Drugs and Vaccines Product Portfolio Table 163. Roche Recent Development Table 164. Novartis Company Information Table 165. Novartis Business Overview Table 166. Novartis Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 167. Novartis Influenza Drugs and Vaccines Product Portfolio Table 168. Novartis Recent Development Table 169. Sanofi Company Information Table 170. Sanofi Business Overview Table 171. Sanofi Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 172. Sanofi Influenza Drugs and Vaccines Product Portfolio Table 173. Sanofi Recent Development Table 174. Changchun Institute of Biological Company Information Table 175. Changchun Institute of Biological Business Overview Table 176. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 177. Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio Table 178. Changchun Institute of Biological Recent Development Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Influenza Drugs and Vaccines Distributors List Table 182. Influenza Drugs and Vaccines Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Influenza Drugs and Vaccines Product Image Figure 2. Global Influenza Drugs and Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Influenza Drugs and Vaccines Sales (2021-2032) & (Tons) Figure 5. Global Influenza Drugs and Vaccines Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Influenza Drugs and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Influenza Drugs Image Figure 10. Influenza Vaccines Image Figure 11. Global Influenza Drugs and Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Influenza Drugs and Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Influenza Drugs and Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Influenza Drugs and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Influenza Drugs and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Influenza Drugs and Vaccines Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Global Influenza Drugs and Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Influenza Drugs and Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Influenza Drugs and Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global Influenza Drugs and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Influenza Drugs and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Influenza Drugs and Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Influenza Drugs and Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Influenza Drugs and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Influenza Drugs and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America Influenza Drugs and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Influenza Drugs and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Influenza Drugs and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America Influenza Drugs and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Influenza Drugs and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Influenza Drugs and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Influenza Drugs and Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Influenza Drugs and Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Drugs
  • Influenza Vaccines
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • CSL
  • Alvogen
  • AstraZeneca
  • BioCryst Pharmaceuticals
  • Bristol Myers Squibb
  • Celgene
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hulan Bio
  • Protein Sciences Corporation
  • Seqirus
  • Serum Institute of India
  • Viatris
  • Beike Bio
  • Bayer
  • Pfizer
  • Jiangsu GDK
  • Sinovac
  • Eli Lilly
  • Roche
  • Novartis
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza Drugs and Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Influenza Drugs and Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Influenza Drugs and Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Influenza Drugs and Vaccines Market Dynamics
  1. 2.1 Influenza Drugs and Vaccines Industry Trends
  2. 2.2 Influenza Drugs and Vaccines Industry Drivers
  3. 2.3 Influenza Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Influenza Drugs and Vaccines Industry Restraints
3 Influenza Drugs and Vaccines Market by Company
  1. 3.1 Global Influenza Drugs and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Influenza Drugs and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Influenza Drugs and Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Influenza Drugs and Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Influenza Drugs and Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Influenza Drugs and Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Influenza Drugs and Vaccines Company Product Type and Application
  8. 3.8 Global Influenza Drugs and Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Influenza Drugs and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Influenza Drugs and Vaccines Market by Type
  1. 4.1 Influenza Drugs and Vaccines Type Introduction
  2. 4.1.1 Influenza Drugs
  3. 4.1.2 Influenza Vaccines
  4. 4.2 Global Influenza Drugs and Vaccines Sales Volume by Type
  5. 4.2.1 Global Influenza Drugs and Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Influenza Drugs and Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Influenza Drugs and Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Influenza Drugs and Vaccines Sales Value by Type
  9. 4.3.1 Global Influenza Drugs and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Influenza Drugs and Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Influenza Drugs and Vaccines Sales Value Share by Type (2021-2032)
5 Influenza Drugs and Vaccines Market by Application
  1. 5.1 Influenza Drugs and Vaccines Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Influenza Drugs and Vaccines Sales Volume by Application
  6. 5.2.1 Global Influenza Drugs and Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Influenza Drugs and Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Influenza Drugs and Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Influenza Drugs and Vaccines Sales Value by Application
  10. 5.3.1 Global Influenza Drugs and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Influenza Drugs and Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Influenza Drugs and Vaccines Sales Value Share by Application (2021-2032)
6 Influenza Drugs and Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Influenza Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Influenza Drugs and Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Influenza Drugs and Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Influenza Drugs and Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Influenza Drugs and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Influenza Drugs and Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Influenza Drugs and Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Influenza Drugs and Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Influenza Drugs and Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Influenza Drugs and Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Influenza Drugs and Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Influenza Drugs and Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Influenza Drugs and Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Influenza Drugs and Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Influenza Drugs and Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Influenza Drugs and Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Influenza Drugs and Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Influenza Drugs and Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Influenza Drugs and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Influenza Drugs and Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Influenza Drugs and Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Influenza Drugs and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Influenza Drugs and Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Influenza Drugs and Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Influenza Drugs and Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Influenza Drugs and Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Influenza Drugs and Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Influenza Drugs and Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Influenza Drugs and Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Influenza Drugs and Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Influenza Drugs and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Alvogen
  8. 8.2.1 Alvogen Company Information
  9. 8.2.2 Alvogen Business Overview
  10. 8.2.3 Alvogen Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
  12. 8.2.5 Alvogen Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 BioCryst Pharmaceuticals
  20. 8.4.1 BioCryst Pharmaceuticals Company Information
  21. 8.4.2 BioCryst Pharmaceuticals Business Overview
  22. 8.4.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
  24. 8.4.5 BioCryst Pharmaceuticals Recent Developments
  25. 8.5 Bristol Myers Squibb
  26. 8.5.1 Bristol Myers Squibb Company Information
  27. 8.5.2 Bristol Myers Squibb Business Overview
  28. 8.5.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
  30. 8.5.5 Bristol Myers Squibb Recent Developments
  31. 8.6 Celgene
  32. 8.6.1 Celgene Company Information
  33. 8.6.2 Celgene Business Overview
  34. 8.6.3 Celgene Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Celgene Influenza Drugs and Vaccines Product Portfolio
  36. 8.6.5 Celgene Recent Developments
  37. 8.7 Emergent Biosolutions
  38. 8.7.1 Emergent Biosolutions Company Information
  39. 8.7.2 Emergent Biosolutions Business Overview
  40. 8.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
  42. 8.7.5 Emergent Biosolutions Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Hulan Bio
  50. 8.9.1 Hulan Bio Company Information
  51. 8.9.2 Hulan Bio Business Overview
  52. 8.9.3 Hulan Bio Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
  54. 8.9.5 Hulan Bio Recent Developments
  55. 8.10 Protein Sciences Corporation
  56. 8.10.1 Protein Sciences Corporation Company Information
  57. 8.10.2 Protein Sciences Corporation Business Overview
  58. 8.10.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
  60. 8.10.5 Protein Sciences Corporation Recent Developments
  61. 8.11 Seqirus
  62. 8.11.1 Seqirus Company Information
  63. 8.11.2 Seqirus Business Overview
  64. 8.11.3 Seqirus Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
  66. 8.11.5 Seqirus Recent Developments
  67. 8.12 Serum Institute of India
  68. 8.12.1 Serum Institute of India Company Information
  69. 8.12.2 Serum Institute of India Business Overview
  70. 8.12.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
  72. 8.12.5 Serum Institute of India Recent Developments
  73. 8.13 Viatris
  74. 8.13.1 Viatris Company Information
  75. 8.13.2 Viatris Business Overview
  76. 8.13.3 Viatris Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Viatris Influenza Drugs and Vaccines Product Portfolio
  78. 8.13.5 Viatris Recent Developments
  79. 8.14 Beike Bio
  80. 8.14.1 Beike Bio Company Information
  81. 8.14.2 Beike Bio Business Overview
  82. 8.14.3 Beike Bio Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
  84. 8.14.5 Beike Bio Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Influenza Drugs and Vaccines Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Pfizer
  92. 8.16.1 Pfizer Company Information
  93. 8.16.2 Pfizer Business Overview
  94. 8.16.3 Pfizer Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
  96. 8.16.5 Pfizer Recent Developments
  97. 8.17 Jiangsu GDK
  98. 8.17.1 Jiangsu GDK Company Information
  99. 8.17.2 Jiangsu GDK Business Overview
  100. 8.17.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
  102. 8.17.5 Jiangsu GDK Recent Developments
  103. 8.18 Sinovac
  104. 8.18.1 Sinovac Company Information
  105. 8.18.2 Sinovac Business Overview
  106. 8.18.3 Sinovac Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
  108. 8.18.5 Sinovac Recent Developments
  109. 8.19 Eli Lilly
  110. 8.19.1 Eli Lilly Company Information
  111. 8.19.2 Eli Lilly Business Overview
  112. 8.19.3 Eli Lilly Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
  114. 8.19.5 Eli Lilly Recent Developments
  115. 8.20 Roche
  116. 8.20.1 Roche Company Information
  117. 8.20.2 Roche Business Overview
  118. 8.20.3 Roche Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Roche Influenza Drugs and Vaccines Product Portfolio
  120. 8.20.5 Roche Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Influenza Drugs and Vaccines Product Portfolio
  126. 8.21.5 Novartis Recent Developments
  127. 8.22 Sanofi
  128. 8.22.1 Sanofi Company Information
  129. 8.22.2 Sanofi Business Overview
  130. 8.22.3 Sanofi Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
  132. 8.22.5 Sanofi Recent Developments
  133. 8.23 Changchun Institute of Biological
  134. 8.23.1 Changchun Institute of Biological Company Information
  135. 8.23.2 Changchun Institute of Biological Business Overview
  136. 8.23.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
  138. 8.23.5 Changchun Institute of Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Influenza Drugs and Vaccines Value Chain Analysis
  2. 9.1.1 Influenza Drugs and Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Influenza Drugs and Vaccines Sales Mode & Process
  6. 9.2 Influenza Drugs and Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Influenza Drugs and Vaccines Distributors
  9. 9.2.3 Influenza Drugs and Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst